In this study, we found that compared with the GNRI, the mGNRI had a better predictive ability for the prognosis of cancer patients and performed better in stratifying the adverse risks of patients, which may be because of the ability of CRP in reflecting systemic inflammation. The gene discussed is CRP; the disease is cancer.